title: Is there a role for a mucosal influenza vaccine in the elderly?
abstract: Influenza infection is an acute respiratory disease with a high morbidity and significant mortality, particularly among the elderly and individuals with chronic diseases. The majority of countries now recommend annual influenza vaccination for all people aged 65 years or older, and for those with high risk conditions. Most commercially available influenza vaccines are administered systemically and while these are effective in children and young adults, efficacy levels in elderly individuals have been reported to be much lower. Mucosal vaccines may offer an improved vaccine strategy for protection of the elderly. As the influenza virus causes a respiratory infection, it is potentially more beneficial to administer a vaccine that will boost protection in the mucosal surfaces of the upper and lower respiratory tract. Mucosal influenza vaccines are aimed at stimulating protective immunity in the respiratory tract via oral or intranasal immunisation. This review examines our present knowledge of mucosal immunity and current strategies for mucosal vaccination. It also stresses that the use of serum antibody levels as a 'surrogate marker' for protection against influenza is potentially misleading; serum antibody, for example, may be a quite inappropriate marker to assess a mucosal vaccine. This marker does not reflect other immune responses to vaccination that are crucial for protection.
authors.affiliation: The Australian Institute of Mucosal Immunology, Royal Newcastle Hospital, New South Wales.
authors.forename: E M
authors.initials: EM
authors.lastname: Corrigan
authors.forename: R L
authors.initials: RL
authors.lastname: Clancy
mesh_terms: D000367:Age Factors; D000368:Aged; D000906:Antibodies / Q000097:blood; D002986:Clinical Trials as Topic; D001908:Diarrhea Viruses, Bovine Viral / Q000502:physiology*; D006801:Humans; D018928:Immunity, Mucosal / Q000187:drug effects; D007252:Influenza Vaccines / Q000276:immunology / Q000627:therapeutic use*; D007251:Influenza, Human / Q000188:drug therapy / Q000276:immunology* / Q000517:prevention & control*; D008954:Models, Biological
chemical_list: D000906:Antibodies; D007252:Influenza Vaccines